Senti Biosciences is a Bay Area biotech company focused on outsmarting complex diseases with more intelligent medicines.

Senti Biosciences leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies.

• Industry

  • Biotechnology

• Milestones

  • Lux investment: 2016

• LUX Partners

  • Adam Goulburn

• Latest Tweets

  • Join us in congratulating Senti's CSO, Gary Lee, for being recognized by #PharmaVoice100 as one of the 100 Most Ins… https://t.co/PCA65bzgQw@SentiBio - 04:27 PM Aug 3rd
  • Tune in with Senti's COO, Philip Lee, for his @ISCTglobal Virtual Presentation on our award-winning abstract tomor… https://t.co/9ZM41nMhbb@SentiBio - 04:14 PM May 27th
  • Join us this week at our virtual #ASGCT20 presentations for an opportunity to dive in with us on the potential of o… https://t.co/4d9EY9nf7i@SentiBio - 04:10 PM May 11th